The World Health Organization has issued new guidance asking countries to build equity explicitly into national plans for antimicrobial resistance.
The document makes a practical point: efforts to reduce antibiotic resistance can fail if they assume that everyone has equal access to clean water, healthcare, diagnosis and appropriate antibiotics.
Why equity changes the AMR problem
Antimicrobial resistance occurs when microorganisms evolve so that medicines used against them become less effective.
Reducing unnecessary antimicrobial use is important, but so is ensuring that people with genuine bacterial infections can obtain effective treatment. A policy that reduces access indiscriminately can therefore create a different kind of harm.
WHO's new guidance focuses on how social and health-system inequalities influence both the emergence of resistance and the impact of interventions intended to control it.
Three practical scenarios
The guidance examines three areas in particular.
The first is water, sanitation and hygiene. Poor access increases infection risk and therefore the need for antimicrobial treatment.
The second is access to health services and essential antibiotics. Some populations face barriers to diagnosis or appropriate treatment even while other settings may have excessive or inappropriate antibiotic use.
The third is surveillance of antimicrobial resistance and antimicrobial consumption. If surveillance systems underrepresent rural, poorer or otherwise underserved groups, national data can give a misleading picture of where resistance is occurring.
Twenty recommendations
WHO provides 20 recommendations spanning the 13 core interventions in its people-centred approach to antimicrobial resistance.
Countries are expected to adapt them to local conditions rather than apply one uniform template.
The central idea is that AMR policy needs to ask not just whether an intervention reduces resistance overall, but also who benefits, who bears the burden and whether the intervention unintentionally worsens existing inequalities.
Why this is relevant to India
India faces both high infectious-disease burden and substantial variation in access to diagnostics, clean water, healthcare and quality-assured medicines.
That makes the tension identified by WHO particularly relevant: antimicrobial stewardship cannot simply mean 'use fewer antibiotics'. It must mean using the right antimicrobial, for the right patient, at the right dose and duration, while preventing infections and preserving access for people who genuinely need treatment.
What to watch next
The significance of the new guidance will depend on implementation.
Useful indicators would include whether national and state AMR plans improve surveillance in underserved populations, expand diagnostics, strengthen infection prevention and maintain access to essential antibiotics while reducing inappropriate use.
Primary source
- World Health Organization. Integration of equity into national action plans on antimicrobial resistance: guidance to complement the people-centred approach. 2 September 2026. https://www.who.int/publications/i/item/9789240123892